Expansion of functional food ingredients through the consolidation of a Spanish lactic acid bacteria company as a subsidiary

「In Supplemental Nutrition, reduced coenzyme Q10 sales expanded in global markets, mainly in the US. The lactic acid bacteria business is also steadily increasing sales.」

「Supplement achieved expanded global sales of reduced-form Q10, particularly in the United States. The lactic acid bacteria business is also steadily increasing sales.」

「In Supplemental Nutrition, sales of reduced coenzyme Q10 expanded, mainly in the US, resulting in higher earnings. Sales expansion in global markets is expected to accelerate further in the second half, with earnings expected to grow steadily.」

「In Supplemental Nutrition, reduced coenzyme Q10 for the US market underwent inventory adjustments in the second quarter due to the反動 from concentrated shipments in the first quarter. Sales expansion in global markets is expected to progress in the second half, with earnings expected to grow steadily.」

「The lactic acid bacteria business, which improves the intestinal environment and promotes prevention of disease, is also steadily expanding sales. We are focusing on developing new markets in the US, the largest market, as well as China, Asia, Russia and Latin America, and on strengthening our production base.」

「In Supplemental Nutrition, reduced coenzyme Q10 sales are growing steadily in the US, Asia and Oceania. We will further strengthen promotional activities with the aim of expanding the market. Sales expansion is also progressing in the lactic acid bacteria business, and we have begun considering the establishment of new production sites. We will steadily expand sales.」

「In Supplemental Nutrition, sales of reduced Q10 are expanding worldwide. Sales targeting China's e-commerce market have also entered full-scale operation. Sales of the lactic acid bacteria business are increasing in Europe, the United States and Asia, and the Company aims for further expansion by strengthening its global production and sales structure.」

「In Supplemental Nutrition, sales of reduced coenzyme Q10 are expanding in the United States, Japan, Europe, Oceania and Asia (China). The Company will strengthen sales for China's e-commerce market. The lactic acid bacteria business is also becoming a contributor, and the Company is expediting the strengthening of its global production and sales structure for supplements.」

「In Supplemental Nutrition, sales of reduced Q10 have expanded beyond the United States and Japan to Europe, Oceania and Asia (China), and the Company is expediting consideration of increased production. In response to the expansion of the lactic acid bacteria business, it is also strengthening its global production and sales structure.」

「In Supplemental Nutrition, AB-Biotics' lactic acid bacteria business expanded substantially. The Company is strengthening its global production and sales structure.」

「In the lactic acid bacteria business, market awareness is increasing and repeat orders in the United States are rising, and the Company will strengthen its production structure.」

「The Company has strengthened its sales base for lactic acid bacteria in the United States, leading to expanded sales.」

「Sales of AB-Biotics' lactic acid bacteria products were strong in Europe. As the next step, the Company will build and strengthen its US production and sales structure and accelerate expansion of sales.」

「In Supplemental Nutrition, sales of reduced coenzyme Q10 in the United States are strong as awareness of immune support increases. Sales of lactic acid bacteria, which are effective in improving gut health, are scheduled to begin in Japan this autumn, following the United States.」

「Sales of lactic acid bacteria began in the United States following strong sales in Europe.」

「The Company made AB-Biotics in Spain a wholly owned subsidiary as a foundation for creating a new Kaneka-style supplement business model centered on branded reduced coenzyme Q10. Its lactic acid bacteria supplement ingredient has been highly valued for its uniqueness, and global sales are expanding. Going forward, the Company will carefully pursue synergies with its food business and communicate scientific information on efficacy and benefits, while diversifying its supplement ingredient portfolio. It will begin production of lactic acid bacteria in the United States at an early stage and rapidly launch sales in the United States and Japan.」

「In Supplemental Nutrition, sales of reduced coenzyme Q10 in the United States progressed steadily. The lactic acid bacteria supplement ingredient of consolidated subsidiary AB-Biotics in Spain has been highly valued for its uniqueness, and global sales are expanding. The Company will strengthen production and sales in the United States and accelerate the global rollout of its functional food business.」

「The lactic acid bacteria supplement ingredient of consolidated subsidiary AB-Biotics in Spain has been highly valued for its uniqueness, and sales in Europe are expanding steadily. Sales in Japan are planned following the United States, and the Company will expand its functional food business globally by enhancing its product lineup.」

「The lactic acid bacteria supplement ingredient of the Spanish lactic acid bacteria company recently made a consolidated subsidiary has been highly valued for its uniqueness, and sales in Europe are expanding steadily. Sales began in the United States in January, and consideration of sales in Japan has begun.」